The application of 2D gel-based proteomics methods to the study of breast cancerSTEIN, Robert C; ZVELEBIL, Marketa J.Journal of mammary gland biology and neoplasia. 2002, Vol 7, Num 4, pp 385-393, issn 1083-3021, 9 p.Article

Combinatorial use of mRNA and two-dimensional electrophoresis expression data to choose relevant features for mass spectrometric identificationPATEL, Ketan; STEIN, Rob; BENVENUTI, Silvia et al.Proteomics (Weinheim. Print). 2002, Vol 2, Num 10, pp 1464-1473, issn 1615-9853, 10 p.Article

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72- polymorphic p53BERGAMASCHI, Daniele; SAMUELS, Yardena; CROOK, Tim et al.Nature genetics. 2006, Vol 38, Num 10, pp 1133-1141, issn 1061-4036, 9 p.Article

A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophreniaRIZIG, Mie A; MCQUILLIN, Andrew; NG, Aylwin et al.Journal of psychopharmacology (Oxford). 2012, Vol 26, Num 9, pp 1218-1230, issn 0269-8811, 13 p.Article

Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-1 7-demethoxygeldanamycinMALONEY, Alison; CLARKE, Paul A; AHERNE, Wynne et al.Cancer research (Baltimore). 2007, Vol 67, Num 7, pp 3239-3253, issn 0008-5472, 15 p.Article

The Vascular Endothelial Growth Factor Receptor Inhibitor PTK787/ ZK222584 Inhibits AromataseBANERJEE, Susana; ZVELEBIL, Marketa; FURET, Pascal et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 11, pp 4716-4723, issn 0008-5472, 8 p.Article

GDNF―RET Signaling in ER-Positive Breast Cancers Is a Key Determinant of Response and Resistance to Aromatase InhibitorsMORANDI, Andrea; MARTIN, Lesley-Ann; QIONG GAO et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 12, pp 3783-3795, issn 0008-5472, 13 p.Article

CYP3A Variation, Premenopausal Estrone Levels, and Breast Cancer RiskJOHNSON, Nichola; WALKER, Kate; BRODERICK, Peter et al.Journal of the National Cancer Institute. 2012, Vol 104, Num 9, pp 657-669, issn 0027-8874, 13 p.Article

Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer riskORR, Nick; LEMNRAU, Alina; MCDADE, Simon S et al.Nature genetics. 2012, Vol 44, Num 11, pp 1182-1184, issn 1061-4036, 3 p.Article

Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferonsNAGANO, Kohji; MASTERS, John R; AKPAN, Akunna et al.Oncogene (Basingstoke). 2004, Vol 23, Num 9, pp 1693-1703, issn 0950-9232, 11 p.Article

Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressorIORNS, Elizabeth; WARD, Toby M; NACEUR-LOMBARELLI, Cristina et al.Breast cancer research and treatment. 2012, Vol 135, Num 1, pp 79-91, issn 0167-6806, 13 p.Article

PPM1D Is a Potential TherapeuticTarget in Ovarian Clear Cell CarcinomasTAN, David S. P; LAMBROS, Maryou B. K; FENWICK, Kerry et al.Clinical cancer research (Print). 2009, Vol 15, Num 7, pp 2269-2280, issn 1078-0432, 12 p.Article

Novel inhibitors of Trypanosoma cruzi dihydrofolate reductaseZUCCOTTO, Fabio; ZVELEBIL, Marketa; BRUN, Reto et al.European journal of medicinal chemistry. 2001, Vol 36, Num 5, pp 395-405, issn 0223-5234Article

The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of CancerFOLKES, Adrian J; AHMADI, Khatereh; FRIEDMAN, Lori S et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 18, pp 5522-5532, issn 0022-2623, 11 p.Article